The U.S. Food and Drug Administration to date has approved seven biosimilars, including Zarxio, Inflectra and Erelzi.
A rundown on the seven biosimilars can be seen at left.
The U.S. Food and Drug Administration to date has approved seven biosimilars, including Zarxio, Inflectra and Erelzi.
A rundown on the seven biosimilars can be seen at left.
(Graphic courtesy of Center for Biosimilars)